How have BIOTU shares performed in 2024?

Biotech Acquisition's stock was trading at $10.14 at the beginning of the year. Since then, BIOTU stock has increased by 0.0% and is now trading at $10.14. View the best growth stocks for 2024 here .

How do I buy shares of Biotech Acquisition?

Shares of BIOTU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:BIOTU

Biotech Acquisition (BIOTU) Stock Price, News & Analysis

→ Your Next Portfolio Star: Revealing 2024's Top Stock Pick (From Darwin) (Ad)

Free BIOTU Stock Alerts

$10.14

-0.84 (-7.65%)

(As of 02/2/2023)

Compare

Today's Range: $10.14
▼
$10.17
50-Day Range: $10.14
▼
$10.14
52-Week Range: $8.73
▼
$11.11

Volume: 1,300 shs
Average Volume: 4,444 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Biotech Acquisition alerts:

Ad Darwin

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

We're thrilled to offer you an exclusive look at the #1 Buy & Hold Stock of 2024. This isn't just any report. It's the culmination of rigorous analysis, expert insights, and cutting-edge financial strategies, distilled into a compelling narrative that charts the course of what we believe to be the year's most promising investment. (**By clicking the link you are subscribing to The Wealth Creation Investing Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

Click here to download your report

About Biotech Acquisition Stock (OTCMKTS:BIOTU)

Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

BIOTU Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BIOTU Stock News Headlines

April 13, 2024 | msn.com

Fujifilm ups US biotech plant investment by $1.2B

March 21, 2024 | msn.com

EXCLUSIVE: 2024 Witnesses Increase In Biotech Initial Public Offerings

April 19, 2024 | Darwin (Ad)

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

February 23, 2024 | msn.com

20 Fastest Growing Biotech Companies in the US

February 19, 2024 | msn.com

Astra Boosts Push Into China Biotech Scene With $1.2 Billion Buy

February 18, 2024 | finance.yahoo.com

CERo Therapeutics Holdings Inc (CERO)

February 7, 2024 | msn.com

Phoenix Biotech Revises CERo Agreement and PIPE Deal

February 7, 2024 | msn.com

Phoenix Biotech’s Strategic Unregistered Equity Sale

April 19, 2024 | Darwin (Ad)

Your Next Portfolio Star: Revealing 2024's Top Stock Pick

February 5, 2024 | bizjournals.com

Here's what could turn around Massachusetts' biotech job market in 2024

January 12, 2024 | realmoney.thestreet.com

4 Biotech Stock Moves I Made Amid a Bullish Call on the Sector

January 8, 2024 | msn.com

Philly biotech execs find ‘optimistic vibe’ at invitation-only JPM Healthcare Conference

January 5, 2024 | msn.com

3 Top Biotech Stocks Worth Adding to Your Portfolio in 2024

January 4, 2024 | seekingalpha.com

Biotech Bonanza: 2024 Biotech Outlook As The Fed Turns Dovish

January 2, 2024 | msn.com

Gene-editing startup Tome Biosciences of Watertown snaps up a San Francisco biotech

December 14, 2023 | msn.com

What Has Insiders Eyeing This Biotech Stock

December 8, 2023 | msn.com

Biotech Deals Are Heating Up. Why 2024 Could Be Even Hotter for M&A.

November 16, 2023 | msn.com

Fortress Biotech GAAP EPS of -$0.94 beats by $1.83, revenue of $34.75M beats by $16M

November 9, 2023 | msn.com

Adaptive Biotech hires Goldman Sachs to explore ‘strategic alternatives’ for key business lines

November 1, 2023 | bizjournals.com

Biotech company led by former Seagen CEO picks Eastside city for new HQ

October 19, 2023 | reuters.com

Risky biotech M&A therapy will heal more fractures

September 27, 2023 | markets.businessinsider.com

7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio

September 5, 2023 | marketwatch.com

Portage Biotech Shares Rise 20% After Keytruda Deal With Merck

August 17, 2023 | msn.com

7 A-Rated Biotech Stocks for Your August Buy List

July 27, 2023 | msn.com

Bharat Biotech picks up 20% stake in Eastman Exports Global Clothing

July 21, 2023 | marketwatch.com

BB Biotech 2Q Loss Narrowed; To Delist From Milan Stock Exchange

July 20, 2023 | msn.com

The 3 Most Undervalued Biotech Stocks to Buy Now: July 2023

See More Headlines

Receive BIOTU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotech Acquisition and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Financial Services
Industry: Shell Companies
Sub-Industry: N/A
Current Symbol: OTCMKTS:BIOTU
CUSIP: N/A
CIK: 1825413
Web: N/A
Phone: N/A
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Dr. Michael Shleifer Ph.D. (Age 49)
Chairman & CEO
Mr. Thomas Fratacci (Age 45)
CFO & Treasurer
Mr. Ivan Jarry (Age 45)
Chief Operating Officer
Mr. Albert F. Hummel M.B.A. (Age 77)
Chief Investment Officer & Director

Key Competitors

View All Competitors

BIOTU Stock Analysis - Frequently Asked Questions

How have BIOTU shares performed in 2024?: Biotech Acquisition's stock was trading at $10.14 at the beginning of the year. Since then, BIOTU stock has increased by 0.0% and is now trading at $10.14.
View the best growth stocks for 2024 here.
How do I buy shares of Biotech Acquisition?: Shares of BIOTU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BIOTU) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Biotech Acquisition (BIOTU) Stock Price, News & Analysis

About Biotech Acquisition Stock (OTCMKTS:BIOTU)

BIOTU Stock Price History

BIOTU Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

BIOTU Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info